Cytosorbents appoints melanie grossman, cpa as vice president and corporate controller

Ms. grossman brings 25 years of accomplished finance and accounting experience in global, publicly-traded companies company announces inducement grant under nasdaq listing rule 5635(c)(4) princeton, n.j. , april 17, 2025 /prnewswire/ -- cytosorbents corporation (nasdaq: ctso), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the appointment of melanie grossman, cpa as vice president and corporate controller.
CPA Ratings Summary
CPA Quant Ranking